Atlas Trials

The Protective Effect of Soluble Beta-1,3/1,6-Glucan Compared to Placebo in Oral Mucositis in Head and Neck Cancer Patients

Clinical trial NCT00289003 · COMPLETED

Trial details

NCT number
NCT00289003
Sponsor
Biotec Pharmacon ASA
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Oral Mucositis
Start date
2003-10-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.